The human OPA1delTTAG mutation induces premature age-related systemic neurodegeneration in mouse.

Dominant optic atrophy is a rare inherited optic nerve degeneration caused by mutations in the mitochondrial fusion gene OPA1. Recently, the clinical spectrum of dominant optic atrophy has been extended to frequent syndromic forms, exhibiting various degrees of neurological and muscle impairments frequently found in mitochondrial diseases. Although characterized by a specific loss of retinal ganglion cells, the pathophysiology of dominant optic atrophy is still poorly understood. We generated an Opa1 mouse model carrying the recurrent Opa1(delTTAG) mutation, which is found in 30% of all patients with dominant optic atrophy. We show that this mouse displays a multi-systemic poly-degenerative phenotype, with a presentation associating signs of visual failure, deafness, encephalomyopathy, peripheral neuropathy, ataxia and cardiomyopathy. Moreover, we found premature age-related axonal and myelin degenerations, increased autophagy and mitophagy and mitochondrial supercomplex instability preceding degeneration and cell death. Thus, these results support the concept that Opa1 protects against neuronal degeneration and opens new perspectives for the exploration and the treatment of mitochondrial diseases.

[1]  V. Nicolas,et al.  Down-regulation of OPA1 alters mouse mitochondrial morphology, PTP function, and cardiac adaptation to pressure overload. , 2012, Cardiovascular research.

[2]  A. Choi,et al.  Mitochondria: commanders of innate immunity and disease? , 2012, Current opinion in immunology.

[3]  M. James,et al.  Effects of Alzheimer's disease transgenes on neurochemical expression in the mouse brain determined by 1H MRS in vitro , 2012, NMR in biomedicine.

[4]  R. Schiffmann,et al.  Early Alterations of Brain Cellular Energy Homeostasis in Huntington Disease Models* , 2011, The Journal of Biological Chemistry.

[5]  P. Chinnery,et al.  Benign neonatal sleep myoclonus: A case with a spinal generator? , 2011, Neurology.

[6]  D. Green,et al.  Mitochondria and the Autophagy–Inflammation–Cell Death Axis in Organismal Aging , 2011, Science.

[7]  W. Robberecht,et al.  HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1–induced Charcot-Marie-Tooth disease , 2011, Nature Medicine.

[8]  G. Dorn,et al.  MARF and Opa1 Control Mitochondrial and Cardiac Function in Drosophila , 2011, Circulation research.

[9]  J. Wansapura,et al.  Cardiac and Skeletal Muscle Defects in a Mouse Model of Human Barth Syndrome* , 2010, The Journal of Biological Chemistry.

[10]  P. Brabet,et al.  Simple and Efficient: Validation of a Cotton Wick Electrode for Animal Electroretinography , 2010, Ophthalmic Research.

[11]  N. Dencher,et al.  Ageing alters the supramolecular architecture of OxPhos complexes in rat brain cortex , 2010, Experimental Gerontology.

[12]  L. Martin Mitochondrial and Cell Death Mechanisms in Neurodegenerative Diseases , 2010, Pharmaceuticals.

[13]  J. Smolen,et al.  Gait changes precede overt arthritis and strongly correlate with symptoms and histopathological events in pristane-induced arthritis , 2010, Arthritis research & therapy.

[14]  J. Heymann,et al.  OPA1 disease alleles causing dominant optic atrophy have defects in cardiolipin-stimulated GTP hydrolysis and membrane tubulation , 2010, Human molecular genetics.

[15]  D. Turnbull,et al.  Multi-system neurological disease is common in patients with OPA1 mutations , 2010, Brain : a journal of neurology.

[16]  P. Heiduschka,et al.  Subtle neurological and metabolic abnormalities in an Opa1 mouse model of autosomal dominant optic atrophy , 2009, Experimental Neurology.

[17]  D. Chan,et al.  Mitochondrial dynamics–fusion, fission, movement, and mitophagy–in neurodegenerative diseases , 2009, Human molecular genetics.

[18]  C. Maier,et al.  Supercomplexes of the mitochondrial electron transport chain decline in the aging rat heart. , 2009, Archives of biochemistry and biophysics.

[19]  J. Mazat,et al.  Development and implementation of standardized respiratory chain spectrophotometric assays for clinical diagnosis. , 2009, Mitochondrion.

[20]  G. Aliev,et al.  In vivo and in vitro assessment of brain bioenergetics in aging rats , 2009, Journal of cellular and molecular medicine.

[21]  D. Turnbull,et al.  OPA1 deficiency associated with increased autophagy in retinal ganglion cells in a murine model of dominant optic atrophy. , 2009, Investigative ophthalmology & visual science.

[22]  Fu-Chin Liu,et al.  Cisd2 deficiency drives premature aging and causes mitochondria-mediated defects in mice. , 2009, Genes & development.

[23]  S. Friedman,et al.  Neuroimaging of mitochondrial disease. , 2008, Mitochondrion.

[24]  J. Enríquez,et al.  Respiratory active mitochondrial supercomplexes. , 2008, Molecular cell.

[25]  S. Ferdinandusse,et al.  Ataxia with loss of Purkinje cells in a mouse model for Refsum disease , 2008, Proceedings of the National Academy of Sciences.

[26]  E. Müller,et al.  Characterization of OPA1 isoforms isolated from mouse tissues , 2008, Journal of neurochemistry.

[27]  R. Youle,et al.  OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion. , 2008, Brain : a journal of neurology.

[28]  R. Schwarzenbacher,et al.  OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes. , 2008, Brain : a journal of neurology.

[29]  Robert W. Taylor,et al.  Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance. , 2008, Brain : a journal of neurology.

[30]  J. McCaffery,et al.  Mitochondrial Fusion Protects against Neurodegeneration in the Cerebellum , 2007, Cell.

[31]  Jennifer R. Davies,et al.  Opa1 deficiency in a mouse model of autosomal dominant optic atrophy impairs mitochondrial morphology, optic nerve structure and visual function. , 2007, Human molecular genetics.

[32]  S. Beck,et al.  A splice site mutation in the murine Opa1 gene features pathology of autosomal dominant optic atrophy. , 2006, Brain : a journal of neurology.

[33]  Sara Cipolat,et al.  OPA1 Controls Apoptotic Cristae Remodeling Independently from Mitochondrial Fusion , 2006, Cell.

[34]  V. Mils,et al.  Mitochondrial dynamics and disease, OPA1. , 2006, Biochimica et biophysica acta.

[35]  R. Homayouni,et al.  The Creatine Kinase/Creatine Connection to Alzheimer's Disease: CK Inactivation, APP-CK Complexes, and Focal Creatine Deposits , 2006, Journal of biomedicine & biotechnology.

[36]  M. L. Greenberg,et al.  Molecular symmetry in mitochondrial cardiolipins. , 2005, Chemistry and physics of lipids.

[37]  L. Pasquier,et al.  Sporadic optic atrophy due to synonymous codon change altering mRNA splicing of OPA1 , 2005, Clinical genetics.

[38]  B. Barbiroli,et al.  Deficit of in vivo mitochondrial ATP production in OPA1‐related dominant optic atrophy , 2004 .

[39]  M. L. Greenberg,et al.  Cardiolipin Biosynthesis and Mitochondrial Respiratory Chain Function Are Interdependent* , 2004, Journal of Biological Chemistry.

[40]  Q. Zhong,et al.  Absence of Cardiolipin Results in Temperature Sensitivity, Respiratory Defects, and Mitochondrial DNA Instability Independent of pet56* , 2004, Journal of Biological Chemistry.

[41]  M. Pericak-Vance,et al.  Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A , 2004, Nature Genetics.

[42]  Kathy Pfeiffer,et al.  Cardiolipin Stabilizes Respiratory Chain Supercomplexes* , 2003, Journal of Biological Chemistry.

[43]  G. Lenaers,et al.  Loss of OPA1 Perturbates the Mitochondrial Inner Membrane Structure and Integrity, Leading to Cytochrome c Release and Apoptosis* , 2003, The Journal of Biological Chemistry.

[44]  D. Vrinten,et al.  ‘CatWalk’ automated quantitative gait analysis as a novel method to assess mechanical allodynia in the rat; a comparison with von Frey testing , 2003, Pain.

[45]  D. Turnbull,et al.  Accumulation of mitochondrial DNA mutations in ageing, cancer, and mitochondrial disease: is there a common mechanism? , 2002, The Lancet.

[46]  J. Grosgeorge,et al.  Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy , 2000, Nature Genetics.

[47]  S. Bhattacharya,et al.  OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28 , 2000, Nature Genetics.

[48]  P. Zaniol,et al.  Defective Brain Energy Metabolism Shown by in vivo 31P MR Spectroscopy in 28 Patients with Mitochondrial Cytopathies , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[49]  P. Chinnery,et al.  OPA1 links human mitochondrial genome maintenance to mtDNA replication and distribution. , 2011, Genome research.

[50]  P. Chinnery,et al.  LETTER TO THE EDITOR OPA1 mutations impair mitochondrial function in both pure and complicated dominant optic atrophy , 2011 .

[51]  A. Munnich,et al.  1H MRS spectroscopy evidence of cerebellar high lactate in mitochondrial respiratory chain deficiency. , 2008, Molecular genetics and metabolism.

[52]  G. Camp,et al.  The Complexity of Age-Related Hearing Impairment: Contributing Environmental and Genetic Factors , 2007 .

[53]  D. W. Robinson,et al.  Age effect in hearing - a comparative analysis of published threshold data. , 1979, Audiology : official organ of the International Society of Audiology.